ArticleJAMA network open2025
Histologic Chorioamnionitis and Neurodevelopment in Preterm Infants.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The special supplemental nutrition program and risk of cerebral palsy.Pediatric research · 2026Article
- The intersection of neuroscience, socioeconomic status, and preterm birth.Pediatric research · 2026Review
- Association of Chorioamnionitis with Early and Late Neonatal Sepsis in Preterm Infants with Gestational Age < 32 Weeks.Diagnostics (Basel, Switzerland) · 2026Article
- Apgar Score Plus Umbilical Artery pH and Adverse Neonatal Outcomes in Very Preterm Infants.JAMA network open · 2026Article
- Association between placental histological chorioamnionitis and respiratory distress syndrome in preterm infants: a retrospective cohort study.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Importance: Exposure to inflammation from chorioamnionitis places the fetus at higher risk of premature birth and may increase the risk of neurodevelopmental impairments, though the evidence for the latter is mixed. Objective: To evaluate whether moderate to severe histologic chorioamnionitis (HCA) is directly associated with adverse motor performance, independent of the indirect mediating effects of premature birth. Design, Setting, and Participants: This prospective, population-based cohort study recruited participants between September 16, 2016, and November 19, 2019, from referral and nonreferral neonatal intensive care units of 5 southwestern Ohio hospitals. Preterm infants of gestational age (GA) 32 weeks or younger were consecutively enrolled. The data were analyzed between January 5 and July 11, 2025. Exposure: Moderate to severe HCA vs no or mild HCA. Main Outcomes and Measures: The primary outcome was the motor score on the standardized Bayley Scales of Infant and Toddler Development, Third Edition (BSID-3), and secondary outcomes were BSID-3 cognitive and language scores. Multivariable regression analyses controlling for antenatal confounding variables were used to test the independent association of HCA with BSID-3 scores, and causal mediation analysis was used to evaluate whether premature birth or birth GA would mediate the association between HCA and neurodevelopmental outcomes. Results: A total of 304 infants (median [IQR] GA, 29.4 [27.3-31.1] weeks; 152 female [50.0%]) had complete data at developmental follow-up at corrected age 22 to 26 months. In multivariable regression analyses, infants exposed to moderate to severe HCA exhibited a decrease in BSID-3 motor scores (β estimate, -7.0; 95% CI, -11.2 to -2.8), cognitive scores (β estimate, -6.0; 95% CI, -10.2 to -1.8, and language scores (β estimate, -8.8; 95% CI, -14.5 to -3.2). Infants exposed to moderate to severe HCA were born at a median GA of 2.6 weeks (IQR, 1.2-4.0 weeks) earlier than those with no or mild HCA exposure. Causal mediation analysis showed that earlier premature birth indirectly mediated 25% of the association of HCA with BSID-3 motor scores (β = -1.7; 95% CI, -2.9 to -0.6). The remaining 75% represented a direct adverse association of HCA or inflammation with motor development (β = -5.3; 95% CI, -9.9 to -0.7). A similar mediation of premature birth was observed for HCA and cognitive scores. Conclusions and Relevance: In this prospective, regional cohort study, exposure to moderate to severe HCA in preterm infants was independently associated with adverse motor neurodevelopment at corrected age 22 to 26 months. Causal mediation analysis suggests that HCA exhibits a significantly mediated association with neurodevelopment via induction of earlier preterm birth and a direct adverse association with neurodevelopmental outcomes. These findings suggest clinical implications for parental counseling and design of anti-inflammatory therapy trials for this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.